Research Article
Astragalus Membranaceus Treatment Protects Raw264.7 Cells from Influenza Virus by Regulating G1 Phase and the TLR3-Mediated Signaling Pathway
Figure 2
Results of anti-influenza Virus activities of AMI for 72 h. , compared with the normal control group. , the treatment group compared with the virus control group.